Gradient2
General Information
DCTPep ID DCTPep02767
Peptide Name Gradient2
Sequence AWLKRIKKFLKALFWVWVW
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Membrane-targeted
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | EC50=19.0 ± 1.8 µM | MTT assay | 24 h | 1 |
A549 | Lung adenocarcinoma | EC50>50 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02767
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C132H192N30O20
Absent amino acids CDEGHMNPQSTY
Theoretical pI 11.33
Acidic residues 0
Basic residues 5
Polar residues 0
Molecular weight (Average) 2519.17
Molecular weight (Monoisotopic) 2517.49
Common amino acids KW
Net charge 5
Instability index (II) 10.78
Aliphatic index 123.16
Grand average of hydropathicity (GRAVY) 0.516
Half Life
4.4 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 22000
Abs 0.1% (=1 g/l) 8.733
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31375699
Title In silico design and optimization of selective membranolytic anticancer peptides
Doi 10.1038/s41598-019-47568-9
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_16627